Mark I Rees Selected Research

Mark I Rees Research Topics

Disease

14	Hyperekplexia 09/2014 - 04/2002
8	Epilepsy (Aura) 01/2021 - 09/2008
4	Malformations of Cortical Development 12/2018 - 02/2013
3	Polymicrogyria 01/2018 - 02/2013
3	Nervous System Diseases (Neurological Disorders) 01/2008 - 04/2002
2	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 12/2018
2	Multiple Sclerosis 01/2023 - 01/2016
2	Inflammation (Inflammations) 01/2023 - 12/2018
2	Brain Diseases (Brain Disorder) 01/2021 - 01/2018
2	Lissencephaly 09/2015 - 02/2013
2	Long QT Syndrome 04/2011 - 04/2006
2	Huntington Disease (Huntington's Disease) 12/2010 - 06/2004
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 06/2004 - 06/2003
1	Epileptic Syndromes 12/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Sudden Unexpected Death in Epilepsy 09/2015
1	Muscle Hypertonia 09/2014
1	Body Weight (Weight, Body) 07/2013
1	Carcinoid Tumor (Carcinoid) 04/2011
1	Heart Diseases (Heart Disease) 04/2011
1	Jervell-Lange Nielsen Syndrome (Jervell and Lange-Nielsen Syndrome) 04/2011
1	Sickle Cell Anemia (Hemoglobin S Disease) 12/2010
1	Cystic Fibrosis (Mucoviscidosis) 12/2010
1	Sudden Death 08/2009
1	Dystonia (Limb Dystonia) 09/2008
1	Nonketotic Hyperglycinemia 01/2008
1	Torsades de Pointes (Torsade de Pointes) 04/2006
1	Heart Arrest (Cardiac Arrest) 04/2006
1	Drug-Related Side Effects and Adverse Reactions 04/2006
1	Atrophy 06/2004
1	Alzheimer Disease (Alzheimer's Disease) 06/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2004
1	Molybdenum cofactor deficiency 07/2003

Drug/Important Bio-Agent (IBA)

7	Glycine Receptors (Glycine Receptor)IBA 11/2013 - 04/2002
5	Proteins (Proteins, Gene)FDA Link 12/2019 - 07/2003
5	Glycine Plasma Membrane Transport ProteinsIBA 10/2013 - 07/2006
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 07/2013
4	TubulinIBA 12/2018 - 02/2013
3	Ligand-Gated Ion ChannelsIBA 04/2014 - 07/2010
3	DNA (Deoxyribonucleic Acid)IBA 04/2013 - 07/2010
3	Nonsense Codon (Nonsense Mutation)IBA 04/2011 - 07/2006
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2016
2	Protein Isoforms (Isoforms)IBA 01/2021 - 07/2003
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2013 - 01/2008
2	gephyrinIBA 01/2008 - 07/2003
2	polyglutamineIBA 06/2004 - 06/2003
2	tributyl phosphate (TBP)IBA 06/2004 - 06/2003
1	Complement Receptors (Complement Receptor)IBA 01/2023
1	AnaphylatoxinsIBA 01/2023
1	Anaphylatoxin C5a ReceptorIBA 01/2023
1	Complement C1q (C1q Complement)IBA 01/2023
1	EnzymesIBA 01/2021
1	fibroblast growth factor 13IBA 01/2021
1	Syntaxin 1IBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	AMPA Receptors (AMPA Receptor)IBA 01/2018
1	LigandsIBA 01/2018
1	ParaffinIBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	Clonazepam (Rivotril)FDA LinkGeneric 09/2014
1	Amino Acids FDA Link 04/2014
1	gamma-Aminobutyric Acid (GABA)IBA 04/2014
1	Aminobutyrates (Aminobutyric Acid)IBA 04/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 07/2013
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2013
1	Levetiracetam (Keppra)FDA LinkGeneric 07/2013
1	Topiramate (Topamax)FDA LinkGeneric 07/2013
1	Lamotrigine (Lamictal)FDA LinkGeneric 07/2013
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 02/2013
1	AcidsIBA 04/2011
1	GastrinsIBA 04/2011
1	Genetic Markers (Genetic Marker)IBA 12/2010
1	Potassium Channels (Potassium Channel)IBA 08/2009
1	Ether (Diethyl Ether)IBA 08/2009
1	GABA-A Receptors (GABA(A) Receptor)IBA 09/2008
1	Cisapride (Propulsid)FDA Link 04/2006
1	sibutramine (Meridia)FDA Link 04/2006
1	Amyloid beta-PeptidesIBA 06/2004
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 06/2003

Therapy/Procedure

1	Therapeutics 01/2023
1	Electrodes (Electrode) 01/2018